‘A special day’: End of Pfizer trial paves way for a COVID shot this year
(Reuters) - Final results from Pfizer Inc's (N:PFE) COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to ...
